Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap55.24B
Enterprise Value54.98B
P/E Ratio52.05
PEG Ratio4.68
Price/Sales Ratio7.75
Price/Book Ratio3.83
Enterprise/Revenue7.66
Enterprise/EBITDA35.37

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.15
Operating Margin0.12
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.08

Income Statement

Revenue4.31B
Revenue/Share4.05
Gross Profit3.13B
EBITDA1.11B
Net Income651.5M
Diluted EPS0.58

Balance Sheet

Total Cash1.83B
Total Cash/Share1.64
Total Debt667.68M
Total Debt/Equity0.07
Current Ratio2.34
Book Value Per Share8.32

Price History

52-Week Change-34.78
52-Week High70.99
52-Week Low29.25
Moving Average 50 Days42.3
Moving Average 200 Days52.25

Statistics

Average Volume17.87M
Shares Outstanding1.11B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.55
Trailing Annual Dividend Yield1.75
Payout Ratio1.65
Last Split Factor8:5
Last Split DateApril 24, 2015
AD